Cancer, TB Drugs Could Be Taiwan’s Niche Biotech Market – BioBusiness Asia Conference
This article was originally published in PharmAsia News
Executive Summary
Taiwan's $2 billion incubator and venture fund will target therapies for locally prevalent cancers in hopes of becoming a regional hub for biotech work.